Name: IMMUNOLOGY2022™
Start: 2022-05-06
End: 2022-05-10
Location: Oregon Convention Center

Chair

Speakers

Angela Desmond, Children’s Hosp. of Philadelphia, Preventing neonatal herpes: Protection after maternal mRNA-lipid nanoparticle vaccination equals or exceeds that from prior maternal genital infection in murine models
Ninaad Lasrado, Univ. of Nebraska-Lincoln, A live-attenuated mutant CVB3 vaccine virus protects against multiple coxsackievirus B infections
Laura Stephens, Univ. of Iowa, Robust efficacy and long-lasting humoral immunity induced by a respiratory syncytial virus prefusion F-based nanoparticle vaccine in genetically diverse animal models
Yinyan Xu, Univ. of North Carolina at Chapel Hill, Conserved-region MVA vaccines can shift HIV T cell immunodominance in PWH on ART—the M&M Study
Celeste Huaman, Uniformed Services Univ., Control of established, CNS-resident lyssavirus infection by an adaptive immune response stimulated by single-dose monoclonal antibody therapy
Husam Taher, Oregon Hlth. and Sci. Univ., T cell programming by the cytomegalovirus MHC class I homologue UL18
Ramireddy Bommireddy, Emory Univ. Sch. of Med., Influenza virus-like particle-based hybrid vaccine containing RBD induces immunity against influenza and SARS-CoV-2 viruses
Marta C. Cruz Cisneros, Univ. of North Carolina at Chapel Hill, Genetic analysis of differential responses to adjuvanted influenza vaccination

Footer